Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!

斯文的傲珊

Lv3

320 积分 2022-12-05 加入

最近求助
最近应助
互助留言

Targeting Death-Associated Protein Kinases for Treatment of Human Diseases: Recent Advances and Future Directions 4天前 已完结
Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis 7天前 已完结
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation 7天前 已完结
Small-Molecule Cyanamide Pan-TEAD·YAP1 Covalent Antagonists 16天前 已完结
Discovery of 10H-Benzo[b]pyrido[2,3-e][1,4]oxazine AXL Inhibitors via Structure-Based Drug Design Targeting c-Met Kinase 16天前 已完结
Discovery of RMC-5552, a Selective Bi-Steric Inhibitor of mTORC1, for the Treatment of mTORC1-Activated Tumors 16天前 已完结
Degrader–Antibody Conjugates: Emerging New Modality 16天前 已完结
Small Molecule Inhibitors of Protein Kinase D: Early Development, Current Approaches, and Future Directions 19天前 已完结
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery 19天前 已完结
Medicinal Chemistry Strategies for the Development of Inhibitors Disrupting β-Catenin’s Interactions with Its Nuclear Partners 19天前 已完结

没有进行任何应助

没有进行任何互助留言

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

科研通是非盈利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

鄂ICP备12009978号-5

鄂公网安备 42011102003731号

科研通【文献互助QQ群】：48029384【点击一键加群】如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通